CN104998179A - Pharmaceutical composition for prevention of rectal carcinoma radioactive skin damage and application thereof - Google Patents

Pharmaceutical composition for prevention of rectal carcinoma radioactive skin damage and application thereof Download PDF

Info

Publication number
CN104998179A
CN104998179A CN201510415877.1A CN201510415877A CN104998179A CN 104998179 A CN104998179 A CN 104998179A CN 201510415877 A CN201510415877 A CN 201510415877A CN 104998179 A CN104998179 A CN 104998179A
Authority
CN
China
Prior art keywords
parts
pharmaceutical composition
prepared
traditional chinese
raw materials
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510415877.1A
Other languages
Chinese (zh)
Inventor
不公告发明人
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510415877.1A priority Critical patent/CN104998179A/en
Publication of CN104998179A publication Critical patent/CN104998179A/en
Pending legal-status Critical Current

Links

Abstract

The invention discloses a pharmaceutical composition for prevention of rectal carcinoma radioactive skin damage and an application thereof; the pharmaceutical composition is prepared from an active component and auxiliary materials; the active component is prepared by water extraction and alcohol precipitation of the following traditional Chinese medicine raw materials in parts by weight: 13-20 parts of potentilla fulgens wall, 12-18 parts of tribulus terrestris, 12-18 parts of mandarin orange seed, 13-20 parts of abelmoschus crinitus wall, 21-30 parts of herba lycopi, 21-30 parts of white atractylodes rhizome, 6-12 parts of fructus amomi, and 10-20 parts of herba hyperici. The pharmaceutical composition not only can delay the generation of radioactive skin damage, ensure smooth performing of radiation therapy and improve tolerability of patient skins on the cumulative dose of radiation, but also can promote healing of radioactive skin damage wound surfaces.

Description

A kind of pharmaceutical composition and application thereof preventing rectal cancer radiation skin injury
Technical field
The invention belongs to technical field of traditional Chinese medicine preparation, prevent pharmaceutical composition of rectal cancer radiation skin injury and its preparation method and application in particular to a kind of.
Background technology
Radiotherapy is the main method of Rectal Carcinomaafter Combined Therapy, and it kills and wounds, inhibition tumor cell also has damage to human normal tissue while breeding.Curing dermal radio lesions is the common complication of radiotherapy patient, for skin microangiopathies under radiation exposure causes a class complication of skin-nourishing obstacle and inflammatory reaction then.Research shows, after skin accepts radiation exposure for a long time, Dermal microvessel endothelial damages, cause microthrombusis widely and microcirculation disturbance in blood capillary, the compact siro spinning technology of blood vessel endothelium is destroyed simultaneously, vessel inner blood composition is caused to exosmose, cause the infringement of local organization, skin rubefaction, itch, pigmentation, thickening coarse, pore is slightly black, moist decortication, vesicle can be there is time serious, then ulceration, rotten to the corn, pain etc., even cause patient radiation to treat and be forced to interrupt, cause patient can not carry out the radiotherapy of rule, affect therapeutic effect (Barlund M, Forozan P, Kononen J, et a1.Detecting activation ribosomal protein S6 kinase by complementalry.DNA and tissue microarray analysis [J] .J Natl Cancer lnst, 2000, 92 (15): 1252.).As can be seen here, radiation skin injury is then inevitable complication in treatment, and severe patient can the damage of concurrent anal canal mucosa, affects the quality of life of patient, is even forced to stopped treatment.Therefore in radiation therapy process, the control of radiation skin injury normally has great importance for radiocurable.
Summary of the invention
The object of the present invention is to provide and a kind ofly prevent pharmaceutical composition of rectal cancer radiation skin injury and its preparation method and application.This pharmaceutical composition can not only delay the generation of radiation skin injury, ensures radiocurablely to carry out smoothly, improves the toleration of patient skin to radiation accumulated dose, and can promote radiation skin injury wound healing.
In order to realize object of the present invention, inventor, by furtheing investigate folk remedy and improving, finally obtains following technical scheme:
A kind of pharmaceutical composition preventing rectal cancer radiation skin injury, this pharmaceutical composition is made up of active component and adjuvant, and wherein said active component is prepared through water extract-alcohol precipitation by the traditional Chinese medicinal material raw materials of following weight portion and obtains: Folium potentillae velutinae (Radix Potentillae Fulgentis) 13-20 part, Fructus Tribuli 12-18 part, Citrus chachiensis Hort. (C.Suavissima Tanaka) 12-18 part, Hibiscus cancellatus Roxb. 13-20 part, Herba Lycopi 21-30 part, Rhizoma Atractylodis Macrocephalae 21-30 part, Fructus Amomi 6-12 part, Herba Hyperici 10-20 part.
Preferably, the pharmaceutical composition of prevention rectal cancer radiation skin injury described above, wherein said active component is prepared through water extract-alcohol precipitation by the traditional Chinese medicinal material raw materials of following weight portion and obtains: Folium potentillae velutinae (Radix Potentillae Fulgentis) 15-17 part, Fructus Tribuli 14-16 part, Citrus chachiensis Hort. (C.Suavissima Tanaka) 14-16 part, Hibiscus cancellatus Roxb. 15-17 part, Herba Lycopi 24-26 part, Rhizoma Atractylodis Macrocephalae 24-26 part, Fructus Amomi 8-10 part, Herba Hyperici 14-16 part.
In a prepreerence embodiment of the present invention, the pharmaceutical composition of prevention rectal cancer radiation skin injury described above, wherein said active component is prepared through water extract-alcohol precipitation by the traditional Chinese medicinal material raw materials of following weight portion and obtains: Folium potentillae velutinae (Radix Potentillae Fulgentis) 16 parts, Fructus Tribuli 15 parts, Citrus chachiensis Hort. (C.Suavissima Tanaka) 15 parts, Hibiscus cancellatus Roxb. 16 parts, Herba Lycopi 25 parts, the Rhizoma Atractylodis Macrocephalae 25 parts, Fructus Amomi 9 parts, Herba Hyperici 15 parts.
It should be noted that, traditional Chinese medicinal material raw materials source of the present invention is as follows: the dry root of Folium potentillae velutinae (Radix Potentillae Fulgentis) rosaceous plant velutinous cinquefoil Potentilla griffithii Hook.f.var.velutina Card..Fructus Tribuli selects the dry mature fruit of zygophyllaceae plant Fructus Tribuli Tribulus terrestris L..Citrus chachiensis Hort. (C.Suavissima Tanaka) selects the dry seed of rutaceae Citrus reticulata Blanco cv. Chachiensis Citrus chachiensis Hort..Hibiscus cancellatus Roxb. selects Malvaceae plant to become mildewed the dried floral of Radix seu folium abelmoschi moschati Abelmoschus crinitus Wall..Herba Lycopi selects the dry aerial parts of labiate hair leaf lycopus lucidus Lycopus lucidus Turcz.var.hirtus Regel.The dry rhizome of feverfew Rhizoma Atractylodis Macrocephalae Atractylodes macrocephala Koidz. selected by the Rhizoma Atractylodis Macrocephalae.Fructus Amomi selects the dry mature fruit of zingiberaceous plant Fructus Amomi Amomum villosum Lour..Herba Hyperici selects the dry herb of the Hypericum ascyron L. of Garcinia maingayii hypericum ascyron.
In addition, the preparation method of the pharmaceutical composition of prevention rectal cancer radiation skin injury of the present invention is as follows:
(1) traditional Chinese medicinal material raw materials Folium potentillae velutinae (Radix Potentillae Fulgentis) 13-20 part, Fructus Tribuli 12-18 part, Citrus chachiensis Hort. (C.Suavissima Tanaka) 12-18 part, Hibiscus cancellatus Roxb. 13-20 part, Herba Lycopi 21-30 part, Rhizoma Atractylodis Macrocephalae 21-30 part, Fructus Amomi 6-12 part and Herba Hyperici 10-20 part is got, decoct with water and extract 2-5h, decocting liquid adds ethanol after concentrated makes volume alcohol content reach 70-78%, 2-8 DEG C of cold preservation 12-48 hour, filter, filtrate recycling ethanol is also concentrated, dry, obtains Chinese medicine dried cream powder;
(2) fully swollen in distilled water by carbomer, add glycerol and propylene glycol, laurocapram grinding makes moistening, and add triethanolamine and grind to form clear gel substrate, heating in water bath is to 68-73 DEG C;
(3) get Chinese medicine dried cream powder prepared by step (1), and get tween 80 and mixed with propylene glycol, after heating for dissolving, this medicinal liquid is joined in gel-type vehicle prepared by step (2), stir, adding distil water standardize solution, continue to stir, obtain gel.
A large amount of clinical practices finds; for the patient that radiation skin injury occurs; gel of the present invention can prevent wound surface dry; keep wound surface moistening, be conducive to wound granulation tissue growth, simultaneously available protecting wound surface epithelial tissue granule; prevent mummification necrosis and cause skin island to be lost; promote the hypertrophy of fibrous tissue simultaneously, be conducive to wound surface epithelization and healing, play the effect for the treatment of skin acute radiation reaction.
Detailed description of the invention
Be below specific embodiments of the invention, technical scheme of the present invention is done to describing further, but protection scope of the present invention be not limited to these embodiments.Every do not deviate from the present invention's design change or equivalent substituting include within protection scope of the present invention.
Embodiment 1: the preparation of Chinese medicine dried cream powder
Prescription: Folium potentillae velutinae (Radix Potentillae Fulgentis) 1.6kg, Fructus Tribuli 1.5kg, Citrus chachiensis Hort. (C.Suavissima Tanaka) 1.5kg, Hibiscus cancellatus Roxb. 1.6kg, Herba Lycopi 2.5kg, Rhizoma Atractylodis Macrocephalae 2.5kg, Fructus Amomi 0.9kg, Herba Hyperici 1.5kg.
Preparation method: the above-mentioned traditional Chinese medicinal material raw materials getting recipe quantity, cleans roguing, adds water and cover powder 2cm, soak 1-1.2h, pull medical material out and put during multi-functional extractions is filled with and decoct with water secondary, first time totalling medical material 12 times amount purified water, decoct 3h, get decocting liquid, filter, second time adds up the purified water of medical material 10 times amount, decoct 2h, get twice decocting liquid to merge, filter, when being concentrated into 65 DEG C, relative density is the concentrated solution of 1.05; Add ethanol to make to reach 75% containing alcohol volumn concentration, 5 DEG C of cold preservation 24 hours, filter, filtrate recycling ethanol is also concentrated into thick paste, lyophilization, obtains Chinese medicine dried cream powder.
Embodiment 2: the preparation of Chinese medicine gel
Prescription: Chinese medicine dried cream powder 10g, Acritamer 940: 10g, propylene glycol 200g, laurocapram 10g, triethanolamine 10g, tween 80: 10g, adding distil water is to 1000g.
Be spread on by carbomer in appropriate distilled water, fully swelling, add the propylene glycol of glycerol and half recipe quantity, laurocapram grinding makes moistening, adds triethanolamine and grinds to form clear gel substrate, heating in water bath to 70 DEG C.After getting the mixed with propylene glycol heating for dissolving of Chinese medicine dried cream powder (preparing according to the formulation and technology of embodiment 1), tween 80 and second half recipe quantity, join in gel-type vehicle by this medicinal liquid, slow quickening stirs, and adding distil water is to 1000g, continue to stir, obtain golden transparent gel.Do not add Chinese medicine dried cream powder, by same process prepare for Blank gel.
Embodiment 3: the clinical application research of the pharmaceutical composition of Chinese herb on the prevention rectal cancer radiation skin injury
Be diagnosed as capable radiocurable patient 45 example of rectal cancer, man 26 example, female 19 example, 52 ~ 73 years old age, average 57.4 ± 6.9 years old.Be divided into test group 22 example and matched group 23 example after patient selection at random, the sex of two groups of patients, age, the state of an illness, without significant difference, have comparability.Two groups of patients all adopt the radiotherapy of 3DRT scheme, radiotherapy apparatus is Siemens's clinac, ray type is 6MV-X line and 9mev β ray, 1 ~ week, 5 continuous radiotherapy 5 times weekly, be weekly a cycle, in radiotherapy 6 cycle, prescribed dose is 50Gy/15 time, every 2 weeks check CT in Patients During Radiotherapy, assessment therapeutic effect.Test group patient is before radiotherapy after 4h and radiotherapy, and the Traditional Chinese medicine gel using embodiment 2 formulation and technology to prepare is coated with outward, 2 times/d, is cleaned gently by previous ointment cotton swab before each medication.Traditional Chinese medicine gel is coated with thickness 3 ~ 5mm outward; The scope of smearing is greater than irradiation field edge 1cm.Matched group patient is before radiotherapy after 4h and radiotherapy, and the Blank gel using embodiment 2 technique to prepare is coated with outward, 2 times/d, gives 1 ︰ 5000 potassium permanganate solution demibain, 2 times/d after radiotherapy simultaneously.Observe two groups of patients and the time of radiation skin injury and the healing time of radiation skin injury occur.Result of the test shows, the test group generation radiation skin injury time is later than matched group (P < 0.05), radiation skin injury healing time is shorter than matched group (P < 0.01), and difference has statistical significance.
The radiation skin injury time occurs a table 1 liang group patient and healing time compares
Compare with matched group, *p < 0.05, *p < 0.01.

Claims (5)

1. one kind is prevented the pharmaceutical composition of rectal cancer radiation skin injury, this pharmaceutical composition is made up of active component and adjuvant, it is characterized in that: described active component is prepared through water extract-alcohol precipitation by the traditional Chinese medicinal material raw materials of following weight portion and obtains: Folium potentillae velutinae (Radix Potentillae Fulgentis) 13-20 part, Fructus Tribuli 12-18 part, Citrus chachiensis Hort. (C.Suavissima Tanaka) 12-18 part, Hibiscus cancellatus Roxb. 13-20 part, Herba Lycopi 21-30 part, Rhizoma Atractylodis Macrocephalae 21-30 part, Fructus Amomi 6-12 part, Herba Hyperici 10-20 part.
2. the pharmaceutical composition of prevention rectal cancer radiation skin injury according to claim 1, is characterized in that: described active component is prepared through water extract-alcohol precipitation by the traditional Chinese medicinal material raw materials of following weight portion and obtains: Folium potentillae velutinae (Radix Potentillae Fulgentis) 15-17 part, Fructus Tribuli 14-16 part, Citrus chachiensis Hort. (C.Suavissima Tanaka) 14-16 part, Hibiscus cancellatus Roxb. 15-17 part, Herba Lycopi 24-26 part, Rhizoma Atractylodis Macrocephalae 24-26 part, Fructus Amomi 8-10 part, Herba Hyperici 14-16 part.
3. the pharmaceutical composition of prevention rectal cancer radiation skin injury according to claim 2, is characterized in that: described active component is prepared through water extract-alcohol precipitation by the traditional Chinese medicinal material raw materials of following weight portion and obtains: Folium potentillae velutinae (Radix Potentillae Fulgentis) 16 parts, Fructus Tribuli 15 parts, Citrus chachiensis Hort. (C.Suavissima Tanaka) 15 parts, Hibiscus cancellatus Roxb. 16 parts, Herba Lycopi 25 parts, the Rhizoma Atractylodis Macrocephalae 25 parts, Fructus Amomi 9 parts, Herba Hyperici 15 parts.
4. prevent a preparation method for the pharmaceutical composition of rectal cancer radiation skin injury, it is characterized in that, the method comprises the steps:
(1) traditional Chinese medicinal material raw materials Folium potentillae velutinae (Radix Potentillae Fulgentis) 13-20 part, Fructus Tribuli 12-18 part, Citrus chachiensis Hort. (C.Suavissima Tanaka) 12-18 part, Hibiscus cancellatus Roxb. 13-20 part, Herba Lycopi 21-30 part, Rhizoma Atractylodis Macrocephalae 21-30 part, Fructus Amomi 6-12 part and Herba Hyperici 10-20 part is got, decoct with water and extract 2-5h, decocting liquid adds ethanol after concentrated makes volume alcohol content reach 70-78%, 2-8 DEG C of cold preservation 12-48 hour, filter, filtrate recycling ethanol is also concentrated, dry, obtains Chinese medicine dried cream powder;
(2) fully swollen in distilled water by carbomer, add glycerol and propylene glycol, laurocapram grinding makes moistening, and add triethanolamine and grind to form clear gel substrate, heating in water bath is to 68-73 DEG C;
(3) get Chinese medicine dried cream powder prepared by step (1), and get tween 80 and mixed with propylene glycol, after heating for dissolving, this medicinal liquid is joined in gel-type vehicle prepared by step (2), stir, adding distil water standardize solution, continue to stir, obtain gel.
5. the application of the traditional Chinese medicinal material raw materials compositions according to claim 1-3 in the medicine of preparation control rectal cancer radiation skin injury.
CN201510415877.1A 2015-07-15 2015-07-15 Pharmaceutical composition for prevention of rectal carcinoma radioactive skin damage and application thereof Pending CN104998179A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510415877.1A CN104998179A (en) 2015-07-15 2015-07-15 Pharmaceutical composition for prevention of rectal carcinoma radioactive skin damage and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510415877.1A CN104998179A (en) 2015-07-15 2015-07-15 Pharmaceutical composition for prevention of rectal carcinoma radioactive skin damage and application thereof

Publications (1)

Publication Number Publication Date
CN104998179A true CN104998179A (en) 2015-10-28

Family

ID=54371215

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510415877.1A Pending CN104998179A (en) 2015-07-15 2015-07-15 Pharmaceutical composition for prevention of rectal carcinoma radioactive skin damage and application thereof

Country Status (1)

Country Link
CN (1) CN104998179A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013076215A (en) * 2011-09-29 2013-04-25 Daiken Corp Decorative sheet
CN104027516A (en) * 2014-06-03 2014-09-10 陈凯 Preparation method of drug for treating acute radioactive skin injury

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013076215A (en) * 2011-09-29 2013-04-25 Daiken Corp Decorative sheet
CN104027516A (en) * 2014-06-03 2014-09-10 陈凯 Preparation method of drug for treating acute radioactive skin injury

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
罗年华: "《结直肠肿瘤》", 31 March 2005, 科学技术文献出版社 *
陈琴等: "三乙醇胺乳膏对直肠癌放射性皮肤损伤预防及治疗效果观察", 《临床护理》 *

Similar Documents

Publication Publication Date Title
CN106075399A (en) For the compositions of corticosteroid dermatitis, preparation and preparation method and application
CN103989869A (en) Traditional Chinese medicine composition for treating skin wound and use thereof
CN105943558A (en) Application of periplaneta americana in preparation of drug for preventing and treating radiation-induced damage
CN103705878B (en) One treats migraine Chinese medicine preparation
CN101837071B (en) The compositions of plant extract and the application of prophylactic treatment cicatrix
CN106176784A (en) A kind of pharmaceutical composition for dermatitis, application, preparation and preparation method thereof
CN105213557A (en) A kind of Chinese medicine composition for the treatment of eczema
CN104173546A (en) Traditional Chinese medicine liquid for treating rhinitis
CN106620633A (en) Skin repairing cream for tumor patients and preparation method of skin repairing cream
CN108403932A (en) A kind of Chinese medicine compound prescription external preparation and its preparation method and application for treating steroid dependent dermatitis
CN104147198A (en) Traditional Chinese medicine compound for treating papular acne and preparation thereof
CN104491359B (en) It is a kind of to treat canker sore, Chinese medicine composition that pharyngitis swells and ache and preparation method thereof
CN104998179A (en) Pharmaceutical composition for prevention of rectal carcinoma radioactive skin damage and application thereof
CN104491629B (en) A kind of external medicine composition for treating perianal eczema and preparation method thereof
CN109432203B (en) Pharmaceutical composition and traditional Chinese medicine raw material composition for treating non-lactation mastitis
CN105343847A (en) Traditional Chinese medicine composition for treating eczema containing folium artemisiae argyi and preparing method thereof
CN105596600A (en) Patch for treating radiodermatitis and preparing method thereof
CN105106390A (en) Plaster used for treating infantile diarrhea and preparation method thereof
CN103341044A (en) Itching-relieving compound preparation and preparation method thereof
CN104027415B (en) A kind of medicine treating scald and preparation method thereof
CN110522805B (en) Traditional Chinese medicine composition for treating alopecia and preparation method and application thereof
CN111700989B (en) Traditional Chinese medicine composition for dispelling wind, eliminating dampness and treating tinea pedis and preparation method thereof
CN103239646B (en) Chinese medicine effective part composition for treating leucoderma and preparation method thereof
CN108434299B (en) Pharmaceutical composition for treating scapulohumeral periarthritis and preparation method and spray thereof
CN105326899A (en) Traditional Chinese medicine for treating leukoderma and preparation method for traditional Chinese medicine

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20151028

RJ01 Rejection of invention patent application after publication